Supplementary Material.pdf (491.75 kB)
Download file

Supplementary Material – PD-1 Targeted Immunotherapy For Advanced Hepatocellular Cancer: Current Utilization And Outcomes In The United States

Download (491.75 kB)
dataset
posted on 17.02.2022, 10:00 by Figshare Future Science GroupFigshare Future Science Group, Johannes Uhlig, Stacey Stein, Hyun S. Kim

Supplementary Material. PD-1 Targeted Immunotherapy For Advanced Hepatocellular Cancer: Current Utilization And Outcomes In The United States

Supplemental Table 1: ICD 09 and ICD 10 codes used for abstraction of patient comorbidities.

Supplemental Table 2: comorbidities of included patients.

Supplemental Figure 1: proportion of advanced HCC receiving PD-1 IMT according to US geography.

Supplemental Figure 2: interaction analyses showing treatment effectiveness of PD-1 IMT versus no PD-1 IMT across patient subgroups. P-values were adjusted for multiplicity using the Bonferroni correction.

History